The IVIG treatment response in autoimmune polyendocrine syndromes type 2 with anti-GAD65 antibody-associated stiff person syndrome: a case report and literature review.
Yang Y, Jiang H, Yang W, Wang H, Wang M, Li X, Huang P, Fang S, Hao W, Yang Y, Zhao F, He W.
Front Immunol. 2025 Jan 7;15:1471115. doi: 10.3389/fimmu.2024.1471115. eCollection 2024.
PMID:39840065
Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O.
N Engl J Med. 2008 Mar 6;358(10):1018-28. doi: 10.1056/NEJMoa0706487.
PMID:18322283
Psoriasis in autoimmune polyendocrine syndrome type I: a possible complication or a non-endocrine minor component?
Poojary SA, Lodha N, Gupta N.
Indian J Dermatol Venereol Leprol. 2015 Mar-Apr;81(2):166-9. doi: 10.4103/0378-6323.152285.
PMID:25751334
A Case of Autoimmune Polyendocrine Syndrome Type 3B and Peripheral Neuropathy Due to Thiamine Deficiency.
Suzuki A, Hayashi K, Hayashi M, Nakaya Y, Sato M.
Cureus. 2024 Jan 11;16(1):e52123. doi: 10.7759/cureus.52123. eCollection 2024 Jan.
PMID:38344613
Autoimmune polyendocrine syndrome type 2 in children: a case report and literature review.
Liu Y, Wang F, Zhang L, Zhang H, Zhu Y.
BMC Pediatr. 2025 May 2;25(1):351. doi: 10.1186/s12887-025-05697-3.
PMID:40316945
Autoimmune polyglandular syndrome type 2: A case report.
Bakkour A, Zakkor MD, Taha Khairy L, Horo R, Mohammed Sharif Ahmed E, Alhussein H.
Ann Med Surg (Lond). 2022 May 16;78:103742. doi: 10.1016/j.amsu.2022.103742. eCollection 2022 Jun.
PMID:35600201
Introduction: Autoimmune polyendocrine syndrome type 1 (APS-1): a rare monogenic disorder as a model to improve understanding of tolerance and autoimmunity.